当前位置:首页 - 行情中心 - 苑东生物(688513) - 财务分析

苑东生物

(688513)

  

流通市值:105.67亿  总市值:105.67亿
流通股本:1.77亿   总股本:1.77亿

苑东生物(688513)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润2.20亿元,每股收益1.25元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益286598.11万元,未分配利润127569.50万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产355892.20万元,负债69294.10万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入1,019,133,615.33654,448,569.46305,640,342.421,349,755,302.66
营业总成本830,690,066.9546,061,623.3259,521,097.681,161,906,337.64
其他经营收益
营业利润241,755,591.93149,624,873.0862,469,083.72251,980,464.19
利润总额242,089,808.95149,737,456.962,412,550.25252,588,308.23
净利润220,162,482.66136,571,926.0860,590,351.64238,234,159.3
每股收益
其他综合收益----
综合收益总额220,162,482.66136,571,926.0860,590,351.64238,234,159.3
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,075,169,166.492,014,818,525.491,997,068,633.71,928,705,677.43
非流动资产:
非流动资产合计1,483,752,866.611,447,684,908.341,463,776,712.341,471,421,823.17
资产总计3,558,922,033.13,462,503,433.833,460,845,346.043,400,127,500.6
流动负债:
流动负债合计593,267,342.68581,818,862.32593,426,868.84596,319,034.66
非流动负债:
非流动负债合计99,673,628.72100,601,555.52104,457,001.94105,886,889.91
负债合计692,940,971.4682,420,417.84697,883,870.78702,205,924.57
所有者权益(或股东权益):
归属于母公司股东权益合计2,865,981,061.72,780,083,015.992,762,961,475.262,697,921,576.03
股东权益合计2,865,981,061.72,780,083,015.992,762,961,475.262,697,921,576.03
负债和股东权益合计3,558,922,033.13,462,503,433.833,460,845,346.043,400,127,500.6
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计1,159,913,582.8782,913,223.47378,598,305.971,550,771,303.32
经营活动现金流出小计941,095,392.1625,440,564.97329,640,506.21,287,530,934.07
经营活动产生的现金流量净额218,818,190.7157,472,658.548,957,799.77263,240,369.25
投资活动产生的现金流量:
投资活动现金流入小计626,626,627.23615,500,811.29281,557,404.752,251,681,476
投资活动现金流出小计1,212,819,804.56913,422,526.82832,865,382.892,055,050,548.05
投资活动产生的现金流量净额-586,193,177.33-297,921,715.53-551,307,978.14196,630,927.95
筹资活动产生的现金流量:
筹资活动现金流入小计180,286,944.98130,014,698.5553,275,359.96194,759,454.47
筹资活动现金流出小计217,893,558.48152,072,408.2725,127,099.78457,024,867.34
筹资活动产生的现金流量净额-37,606,613.5-22,057,709.7228,148,260.18-262,265,412.87
汇率变动对现金及现金等价物的影响-194,430.12,612.2318,950.7631,963.75
现金及现金等价物净增加额-405,176,030.23-162,504,154.52-474,182,967.43197,637,848.08
期末现金及现金等价物余额560,002,474.96802,674,350.67490,995,537.76965,178,505.19
补充资料:
现金及现金等价物的净增加额--162,504,154.52-197,637,848.08
最新报告期:2025-10-29
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
太平洋张懿,谭紫媚1.391.581.892025-10-29
中信建投袁清慧,贺菊颖1.541.812.162025-09-02
太平洋张懿,谭紫媚1.491.762.112025-08-21
西部证券李梦园1.601.952.442025-08-21
开源证券刘艺,余汝意1.531.802.152025-08-21
TOP↑